-Bloomberg
Aileron Therapeutics Q1 EPS $(0.08) Up From $(0.24) YoY
Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.08) per share. This is a 66.67 percent increase over losses of $(0.24) per share from the same period last year.